Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.54 USD
-0.06 (-3.75%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.55 +0.01 (0.65%) 6:26 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 13.04% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.71 |
Next Year | -0.66 |
EPS (TTM) | -0.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00M | 2.41M | 25.47M | 71.60M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 1.00M | 3.01M | 40.14M | 103.09M |
Low Estimate | 1.00M | 1.80M | 10.80M | 40.10M |
Year ago Sales | 0.02M | 0.32M | 1.21M | 25.47M |
Year over Year Growth Est. | 4,900.00% | 651.56% | 2,013.69% | 181.10% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.18 | -0.71 | -0.66 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.20 | -0.15 | -0.67 | -0.62 |
Low Estimate | -0.20 | -0.21 | -0.75 | -0.69 |
Year ago EPS | -0.17 | -0.22 | -0.79 | -0.71 |
Year over Year Growth Est. | -17.65% | 18.18% | 10.13% | 7.75% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.18 | -0.71 | -0.66 |
7 Days Ago | -0.20 | -0.18 | -0.71 | -0.66 |
30 Days Ago | -0.20 | -0.18 | -0.71 | -0.66 |
60 Days Ago | -0.24 | -0.23 | -0.86 | -0.70 |
90 Days Ago | -0.22 | -0.21 | -0.76 | -0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.18 | -0.71 | -0.66 |
Zacks Consensus Estimate | -0.20 | -0.18 | -0.71 | -0.66 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.21 | -0.22 | -0.17 | NA |
Estimate | -0.23 | -0.22 | -0.17 | -0.17 | NA |
Difference | 0.03 | 0.01 | -0.05 | 0.00 | 0.00 |
Surprise | 13.04% | 4.55% | -29.41% | 0.00% | -2.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more